Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting S100A9–ALDH1A1–Retinoic Acid Signaling to Suppress Brain Relapse in EGFR-Mutant Lung Cancer
Anup Biswas, Seo-Young Han, Yifan Tai, et al.
Cancer Discovery (2022) Vol. 12, Iss. 4, pp. 1002-1021
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

S100A8 and S100A9 in Cancer
Yu Chen, Yuzhen Ouyang, Zhixin Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188891-188891
Closed Access | Times Cited: 61
Aldehyde dehydrogenase in solid tumors and other diseases: Potential biomarkers and therapeutic targets
Jie Xia, Siqin Li, Suling Liu, et al.
MedComm (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 39
ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy
Kousalya Lavudi, Shreya Madhav Nuguri, Prashant Pandey, et al.
Life Sciences (2024) Vol. 356, pp. 123033-123033
Closed Access | Times Cited: 13
ALDH1: A potential therapeutic target for cancer stem cells in solid tumors
Yaolu Wei, Yan Li, Yen‐An Chen, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 58
Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism
Cátia Monteiro, Lauritz Miarka, María Perea-García, et al.
Nature Medicine (2022) Vol. 28, Iss. 4, pp. 752-765
Open Access | Times Cited: 52
Targeting macrophages: a novel treatment strategy in solid tumors
Mengmeng Liu, Lina Liu, Yongping Song, et al.
Journal of Translational Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 41
Targeting the retinoic acid signaling pathway as a modern precision therapy against cancers
Kousalya Lavudi, Shreya Madhav Nuguri, Zianne Olverson, et al.
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 32
Anti-EGFR ScFv functionalized exosomes delivering LPCAT1 specific siRNAs for inhibition of lung cancer brain metastases
Jun Jiang, Yuan Lu, Jie Chu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 7
Multi-stage mechanisms of tumor metastasis and therapeutic strategies
Zaoqu Liu, Jingqi Chen, Yuqing Ren, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 7
Refining the optimal CAF cluster marker for predicting TME-dependent survival expectancy and treatment benefits in NSCLC patients
Kai Li, Rui Wang, Guowei Liu, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 5
Risk factors for brain metastasis in lung cancer: an umbrella review of systematic reviews and meta-analyses
Xinliang Wan, Handan Mo, Jixin Chen, et al.
BMJ Open (2025) Vol. 15, Iss. 1, pp. e087181-e087181
Open Access
Targeting the S100A9/P38 MAPK/HSPB1 axis as a novel approach for aortic dissection therapy
Likang Ma, Linfeng Xie, Qingsong Wu, et al.
International Immunopharmacology (2025) Vol. 149, pp. 114225-114225
Closed Access
Cancer brain metastasis: molecular mechanisms and therapeutic strategies
Yucheng Lu, Ying Huang, Cuiqing Zhu, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access
RBM10 deficiency promotes brain metastasis by modulating sphingolipid metabolism in a BBB model of EGFR mutant lung adenocarcinoma
Gang Xu, Bo An, Ruqiong Wang, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Brain metastatic outgrowth and osimertinib resistance are potentiated by RhoA in EGFR-mutant lung cancer
Sally J. Adua, Anna Arnal Estape, Minghui Zhao, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 20
Targeting TAM-secreted S100A9 effectively enhances the tumor-suppressive effect of metformin in treating lung adenocarcinoma
Qihai Sui, Zhengyang Hu, Jiaqi Liang, et al.
Cancer Letters (2023) Vol. 581, pp. 216497-216497
Closed Access | Times Cited: 11
ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase θ expression
Kousalya Lavudi, Ananya Banerjee, Na Li, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 10
Oncogenic enhancers prime quiescent metastatic cells to escape NK immune surveillance by eliciting transcriptional memory
Daniela Michelatti, Sven Beyes, Chiara Bernardis, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 3
Advances in the study of S100A9 in cardiovascular diseases
Fengling Chen, Ziyu He, Chengming Wang, et al.
Cell Proliferation (2024) Vol. 57, Iss. 8
Open Access | Times Cited: 3
ALDH1A1 confers resistance to RAF/MEK inhibitors in melanoma cells by maintaining stemness phenotype and activating PI3K/AKT signaling
Valerio Ciccone, Vittoria Simonis, Cinzia Del Gaudio, et al.
Biochemical Pharmacology (2024) Vol. 224, pp. 116252-116252
Open Access | Times Cited: 3
Prognostic Biomarkers for Hepatocellular Carcinoma Based on Serine and Glycine Metabolism-related Genes
Xufan Cai, Fang Xu, Zhaohong Wang, et al.
Journal of Clinical and Translational Hepatology (2024) Vol. 000, Iss. 000, pp. 000-000
Open Access | Times Cited: 2
ALDH1A1 as a marker for metastasis initiating cells: a mechanistic insight
Nandini Datta, V. P. Snijesh, K Parvathy, et al.
Experimental Cell Research (2024) Vol. 442, Iss. 1, pp. 114213-114213
Closed Access | Times Cited: 2
Targeting ALDH1A1 to enhance the efficacy of KRAS-targeted therapy through ferroptosis
Yunyi Bian, Guangyao Shan, Guoshu Bi, et al.
Redox Biology (2024) Vol. 77, pp. 103361-103361
Open Access | Times Cited: 2
Study on Potential Differentially Expressed Genes in Idiopathic Pulmonary Fibrosis by Bioinformatics and Next-Generation Sequencing Data Analysis
Muttanagouda Giriyappagoudar, Basavaraj Vastrad, Rajeshwari Horakeri, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3109-3109
Open Access | Times Cited: 7
Unraveling the Impact of Intratumoral Heterogeneity on EGFR Tyrosine Kinase Inhibitor Resistance in EGFR-Mutated NSCLC
Keigo Kobayashi, Aaron C. Tan
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 4126-4126
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top